Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-23-007325
Filing Date
2023-11-13
Accepted
2023-11-13 16:38:25
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nexalintechno_10q.htm   iXBRL 10-Q 1305265
2 EXHIBIT 31.1 nexalintechno_ex31-1.htm EX-31.1 11351
3 EXHIBIT 32.1 nexalintechno_ex32-1.htm EX-32.1 5512
  Complete submission text file 0001829126-23-007325.txt   5537179

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nxl-20230930.xsd EX-101.SCH 36582
5 XBRL CALCULATION FILE nxl-20230930_cal.xml EX-101.CAL 53240
6 XBRL DEFINITION FILE nxl-20230930_def.xml EX-101.DEF 135925
7 XBRL LABEL FILE nxl-20230930_lab.xml EX-101.LAB 259901
8 XBRL PRESENTATION FILE nxl-20230930_pre.xml EX-101.PRE 224142
55 EXTRACTED XBRL INSTANCE DOCUMENT nexalintechno_10q_htm.xml XML 951064
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41507 | Film No.: 231399505
SIC: 3845 Electromedical & Electrotherapeutic Apparatus